BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
7/21/2021 8:24:09 AM | Browse: 611 | Download: 2230
 |
Received |
|
2021-02-24 08:44 |
|
Peer-Review Started |
|
2021-02-24 08:48 |
|
First Decision by Editorial Office Director |
|
2021-04-18 03:44 |
|
Return for Revision |
|
2021-04-18 04:29 |
|
Revised |
|
2021-05-02 02:22 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2021-05-26 12:33 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2021-05-26 13:03 |
|
Articles in Press |
|
2021-05-26 13:03 |
|
Edit the Manuscript by Language Editor |
|
2021-06-10 00:45 |
|
Typeset the Manuscript |
|
2021-07-14 05:32 |
|
Publish the Manuscript Online |
|
2021-07-21 08:24 |
| ISSN |
2307-8960 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Infectious Diseases |
| Manuscript Type |
Case Control Study |
| Article Title |
Soluble programmed death-1 is predictive of HBsAg loss in chronic hepatitis B patients after antiviral treatment
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Ning Tan, Hao Luo, Qian Kang, Jia-Li Pan, Ran Cheng, Hong-Li Xi, Hong-Yu Chen, Yi-Fan Han, Yu-Qing Yang and Xiao-Yuan Xu |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| the 13th Five-Year Plan of Ministry of Science and Technology of the People’s Republic of China |
2017ZX10302201-004-009 |
| the 13th Five-Year Plan of Ministry of Science and Technology of the People’s Republic of China |
2017ZX10203202-003 |
| Beijing Municipal Science and Technology Commission of Major Projects |
D161100002716002 |
| Beijing Municipal Science and Technology Commission of Major Projects |
D161100002716003 |
|
| Corresponding Author |
Xiao-Yuan Xu, MD, Chief Physician, Professor, Department of Infectious Diseases, Peking University First Hospital, No.8 Xishiku Street, Beijing 100034, China. xiaoyuanxu6@163.com |
| Key Words |
Programmed cell death 1 protein; Hepatitis B surface antigen; Chronic hepatitis B; Antiviral; Nucleos(t)ide analogs; Hepatitis B e antigen |
| Core Tip |
This study analyzed the data and samples from patients with chronic hepatitis B who underwent antiviral treatment and were followed up for 12 years to investigate the factors associated with hepatitis B surface antigen (HBsAg) loss and explore the impact of soluble programmed death-1 (sPD-1) levels. The sPD-1 Levels were significantly different between patients with and without HBsAg loss during antiviral treatment. The sPD-1 Levels at 6 mo can predict HBsAg loss after 12 years of antiviral treatment. |
| Publish Date |
2021-07-21 08:24 |
| Citation |
Tan N, Luo H, Kang Q, Pan JL, Cheng R, Xi HL, Chen HY, Han YF, yang YP, Xu XY. Soluble programmed death-1 is predictive of HBsAg loss in chronic hepatitis B patients after antiviral treatment . World J Clin Cases 2021; 9(21): 5812-5821 |
| URL |
https://www.wjgnet.com/2307-8960/full/v9/i21/5812.htm |
| DOI |
https://dx.doi.org/10.12998/wjcc.v9.i21.5812 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
